All News about Halozyme Therapeutics, Inc. - Common Stock


Via Benzinga

Halozyme Therapeutics: Q1 Earnings Insights
May 09, 2023
Via Benzinga

Halozyme Therapeutics Earnings Preview
May 08, 2023
Via Benzinga

The Latest Analyst Ratings for Halozyme Therapeutics
March 16, 2023
Via Benzinga

5 Analysts Have This to Say About Halozyme Therapeutics
February 22, 2023
Via Benzinga

Halozyme Therapeutics's Earnings: A Preview
February 20, 2023
Via Benzinga
Where Halozyme Therapeutics Stands With Analysts
December 08, 2022
Via Benzinga
5 Analysts Have This to Say About Halozyme Therapeutics
December 08, 2022
Via Benzinga



Via Benzinga



4 Analysts Have This to Say About Halozyme Therapeutics
November 22, 2022
Via Benzinga

Via Benzinga




Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022
November 28, 2022
Via Benzinga




Stocks That Hit 52-Week Lows On Friday
November 25, 2022
Via Benzinga



Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.